With regard to the XRCC1-Arg280His polymorphism and prostate cancer, a significant association was found under the heterozygote model AH vs. AA (OR = 1.68, 95%CI = 1.12–2.51, P = 0.012)(Figure 2. This evidence concerns the gene XRCC1 and prostate carcinoma.